Cargando…
A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series
Lusutrombopag is a thrombopoietin receptor agonist which reduces the need for platelet transfusions before planned invasive procedures. A post hoc analysis of data from the registration trials observed that lusutrombopag-treated patients who achieved a platelet count > 50 × 10(9)/L (responder pat...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646676/ https://www.ncbi.nlm.nih.gov/pubmed/36343065 http://dx.doi.org/10.1097/MD.0000000000031429 |